SMS Pharmaceuticals Ltd SMSPHARMA-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 10/04/22 IST
90.75quote price arrow up+0.35 (+0.39%)
Volume
35,399
52 week range
68.40 - 160.65
Loading...
  • Open91.25
  • Day High93.55
  • Day Low90.10
  • Prev Close90.40
  • 52 Week High160.65
  • 52 Week High Date10/08/21
  • 52 Week Low68.40
  • 52 Week Low Date06/09/22

Key Stats

  • Market Cap91.76M
  • Shares Out84.65M
  • 10 Day Average Volume34,320.36
  • Dividend0.30
  • Dividend Yield0.33%
  • Beta-
  • YTD % Change-29.16

KEY STATS

  • Open91.25
  • Day High93.55
  • Day Low90.10
  • Prev Close90.40
  • 52 Week High160.65
  • 52 Week High Date10/08/21
  • 52 Week Low68.40
  • 52 Week Low Date06/09/22
  • Market Cap91.76M
  • Shares Out84.65M
  • 10 Day Average Volume34,320.36
  • Dividend0.30
  • Dividend Yield0.33%
  • Beta-
  • YTD % Change-29.16

RATIOS/PROFITABILITY

  • EPS (TTM)3.04
  • P/E (TTM)29.87
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/22/2022
  • Div Amount0.30
  • Split Date-
  • Split Factor-

Latest On SMS Pharmaceuticals Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients (API) and their intermediates. The Company's API products include Ranitidine HCL (Form-2) USP / Ph.Eur, Famotidine USP / Ph. Eur / JP, Pantoprazole Sodium Sesquihydrate US/Ph. Eur, Itraconazole USP / Ph.Eur / JP, Lanoconazole USP / JP, Sumatriptan Succinate USP / Ph.Eur/ BP, Sumatriptan Base USP / Ph.Eur/ BP...
Ramesh Potluri
Executive Chairman of the Board, Managing Director
Lakshmi Tammineedi
Chief Financial Officer
Address
Plot No.19-III,OP BHARATIYA VIDYA BHAVAN
PUBLIC ROAD NO 71, JUBILEE HILLS
Hyderabad
500096
India